| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |